Video 14 Nov 2024 Stockhead Long Shortz | No nerves as company enters US market Orthocell Chairman John Van Der Wielen spoke with Stockhead to discuss the Company's strategic positioning ahead of its US market… Orthocell
Video 14 Nov 2024 Meet The Board | Independent Director, Dr. Ravi Thadhani The fourth episode of Orthocell's 'Meet the Board' video series is now live - featuring Independent Director, Dr. Ravi Thadhani. Orthocell
Company News 11 Nov 2024 Appointment of Key US Executives to Lead Remplir™ Launch Orthocell has appointed two experienced US-based executives to drive the market launch and sales of Remplir™ following the expected US… Orthocell
Audio 01 Nov 2024 Equity Mates Podcast Orthocell has been named as a biotech stock to watch on a recent episode the Equity Mates Investing Podcast. Orthocell
Media 25 Oct 2024 The West Australian | Orthocell confirms record $17 million raising to launch in the US Orthocell's record $17 million capital raise has been featured in The West Australian newspaper in an article titled "Orthocell confirms… Orthocell
Company News 25 Oct 2024 $17 million placement to fund US launch of Remplir™ and drive further growth Orthocell has today announced that it has received firm commitments for a $17 million capital raising via an institutional placement. Orthocell
Video 22 Oct 2024 Meet The Board | Chairman, John Van Der Wielen The third episode of Orthocell’s ‘Meet the Board’ video series is now online - featuring Chairman, John Van Der Wielen. Orthocell
Video 16 Oct 2024 Executive Series | Meet The Board | Professor Fiona Wood AM In the second instalment of the ‘Meet The Board’ video series, we meet Professor Fiona Wood, a world-renowned plastic and… Orthocell
Company News 08 Oct 2024 Orthocell Receives Regulatory Approval for Remplir™ in Singapore Orthocell has received regulatory approval from the Health Sciences Authority (HSA) in Singapore, allowing the Company to commence sales of… Orthocell
Company News 07 Oct 2024 Orthocell Reports Second Consecutive Quarter of Record Revenue Orthocell has today announced continued growth in sales of its market-leading medical devices, Striate+™ and Remplir™. Orthocell
